Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes

Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes severe hepatitis, with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we study the impact of HDV on viral antigen processing and presentation. Us...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Rep Med
Autori principali: Tham, Christine Y.L., Kah, Janine, Tan, Anthony T., Volz, Tassilo, Chia, Adeline, Giersch, Katja, Ladiges, Yvonne, Loglio, Alessandro, Borghi, Marta, Sureau, Camille, Lampertico, Pietro, Lütgehetmann, Marc, Dandri, Maura, Bertoletti, Antonio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659593/
https://ncbi.nlm.nih.gov/pubmed/33205065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100060
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi